Fairness opinions › Acquirers
C. R. Bard: healthcare acquisitions with fairness opinions
2 public-company targets, 2013-2015, $443M combined enterprise value. The multiples C. R. Bard paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
12.3x
Median EV / revenue paid
2.63x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2015-11-20 | Liberator Medical Holdings | C. R. Bard | Medical Devices and Supplies | $181M | 11.5x | 2.01x | 12.0%–16.0% | JMP Securities |
| 2013-11-13 | Rochester Medical | C. R. Bard | Medical Devices and Supplies | $262M | 13.1x | 3.25x | 16.4%–18.6% |